ArticleCancer immunology, immunotherapy : CII2023

Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models.

Hiroyuki Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.